Quantifying Bone and Skin Movement in the Residual Limb of Individuals With Transtibial Amputation Using Dynamic Stereo X-Ray
Launched by VA OFFICE OF RESEARCH AND DEVELOPMENT · Mar 9, 2022
Trial Information
Current as of June 28, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how movement occurs between the residual limb (the part of the leg remaining after amputation) and the prosthetic socket in individuals who have had a transtibial amputation (below the knee). Researchers want to understand how different types of prosthetic suspension systems – specifically suction and elevated vacuum – affect this movement. By using a special imaging technique called dynamic stereo x-ray, they aim to measure the three-dimensional movement of the limb in the socket accurately. This information is important for improving prosthetic designs and ensuring better comfort, stability, and health for users.
To participate in this study, individuals must be at least 18 years old, have had a unilateral transtibial amputation for at least six months, and currently use a prosthetic for at least six hours a day. Participants will undergo imaging tests to capture how their limb moves with different socket types. It's important to note that certain health conditions, such as severe skin issues or mental impairments, may prevent someone from taking part in the study. Overall, this research could help lead to better fitting and functioning prosthetics, making daily life easier for amputees.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Unilateral transtibial amputation (any etiology)
- • At least 18 years old
- • At least 6-months post-amputation
- • Current prosthetic users (at least 6 hours/day)
- Exclusion Criteria:
- • Unable to ambulate on a treadmill at low to moderate speed
- • Inability to tolerate the socket suspensions
- • Length of the residual limb prohibits socket fitting, dynamic stereo x-ray data capture, or marker placement
- • Mental impairment that impedes study compliance
- • Skin conditions (i.e. burns or poor skin coverage) as well as those with severe contractures that prevent prior prosthetic wear
- • Severe neuropathy, uncontrolled diabetes, have insensate foot, severe phantom pain, or a significant history of skin ulcers
- • Any other significant comorbidity that would interfere with the study
- • Severe circulatory problems including peripheral vascular disease and pitting edema
- • Cognitive deficits or mental health problems that would limit ability to participate fully in the study protocol
- • Women who are pregnant or who plan to become pregnant during the study
About Va Office Of Research And Development
The VA Office of Research and Development (ORD) is dedicated to advancing the health and well-being of veterans through innovative research initiatives. As a pivotal sponsor of clinical trials, ORD focuses on a broad spectrum of health-related topics, including mental health, rehabilitation, and chronic disease management, ensuring that findings are directly applicable to the unique needs of the veteran population. With a commitment to scientific excellence and collaboration, ORD promotes rigorous study designs and ethical standards, facilitating the translation of research discoveries into improved clinical practices and policies that enhance veteran care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
New York, New York, United States
New York, New York, United States
Patients applied
Trial Officials
Jason Maikos, PhD
Principal Investigator
VA NY Harbor Healthcare System, New York, NY
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials